4.7 Article

Contributing factors to advanced brain aging in depression and anxiety disorders

Journal

TRANSLATIONAL PSYCHIATRY
Volume 11, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41398-021-01524-2

Keywords

-

Categories

Funding

  1. Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-MW) [10-000-1002]
  2. VU University Medical Center
  3. Leiden University Medical Center
  4. University Medical Center Groningen
  5. Scientific Institute for Quality of Healthcare [IQ healthcare]
  6. Netherlands Institute of Mental Health and Addiction [Trimbos Institute]
  7. GGZ inGeest
  8. Arkin
  9. GGZ Rivierduinen
  10. Lentis
  11. GGZ Friesland
  12. GGZ Drenthe
  13. Lifebrain by the European Union's Horizon 2020 research and innovation programme [732592]
  14. H2020 Societal Challenges Programme [732592] Funding Source: H2020 Societal Challenges Programme

Ask authors/readers for more resources

This study investigated multivariate brain aging in patients with major depressive disorder (MDD) and anxiety disorders, finding that brain predicted age differences (brain PAD) were associated with clinical, somatic, lifestyle, and biological factors. Advanced brain aging in MDD and anxiety patients was most strongly linked to somatic depressive symptomatology.
Depression and anxiety are common and often comorbid mental health disorders that represent risk factors for aging-related conditions. Brain aging has shown to be more advanced in patients with major depressive disorder (MDD). Here, we extend prior work by investigating multivariate brain aging in patients with MDD, anxiety disorders, or both, and examine which factors contribute to older-appearing brains. Adults aged 18-57 years from the Netherlands Study of Depression and Anxiety underwent structural MRI. A pretrained brain-age prediction model based on >2000 samples from the ENIGMA consortium was applied to obtain brain-predicted age differences (brain PAD, predicted brain age minus chronological age) in 65 controls and 220 patients with current MDD and/or anxiety. Brain-PAD estimates were associated with clinical, somatic, lifestyle, and biological factors. After correcting for antidepressant use, brain PAD was significantly higher in MDD (+2.78 years, Cohen's d=0.25, 95% CI -0.10-0.60) and anxiety patients (+2.91 years, Cohen's d=0.27, 95% CI -0.08-0.61), compared with controls. There were no significant associations with lifestyle or biological stress systems. A multivariable model indicated unique contributions of higher severity of somatic depression symptoms (b=4.21 years per unit increase on average sum score) and antidepressant use (-2.53 years) to brain PAD. Advanced brain aging in patients with MDD and anxiety was most strongly associated with somatic depressive symptomatology. We also present clinically relevant evidence for a potential neuroprotective antidepressant effect on the brain-PAD metric that requires follow-up in future research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available